← Eichor
Study identifier: NCT05725096 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Condition: Statin · Cardiovascular Risk Factors · Primary Prevention  ·  Sponsor: Zhang longjiang,MD

PhaseNA
Planned participants3400
Who can joinAll sexes, 40 Years to 69 Years
Healthy volunteersNo

About this study

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.

This description comes directly from the study's public registry record.

Talk to the study team

Longjiang Zhang, MD  ·  13405833167  ·  kevinzhlj@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Research Institute Of Medical Imaging Jinling HospitalNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05725096